about
Applying nanomedicine in maladaptive inflammation and angiogenesis.Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles.Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.Advancement of the Emerging Field of RNA Nanotechnology.Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.Improved In Vivo Efficacy of Anti-Hypertensive Biopeptides Encapsulated in Chitosan Nanoparticles Fabricated by Ionotropic Gelation on Spontaneously Hypertensive Rats.The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.Emerging Roles of Tumor Necrosis Factor-Stimulated Gene-6 in the Pathophysiology and Treatment of Atherosclerosis.Chemotherapeutic Drug Based Metal-Organic Particles for Microvesicle-Mediated Deep Penetration and Programmable pH/NIR/Hypoxia Activated Cancer Photochemotherapy.Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin.Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.
P2860
Q38557650-E52FE436-7CFC-413F-ABF8-AD72037A3283Q38734734-790D4FB1-8822-444A-A4E5-144C83C3AE70Q38789463-EE2AC196-1FD9-427C-A279-17EE0F17A33EQ38937398-06CB5F5F-2380-4DC3-8CBD-00BB4C4F6895Q39065708-56AD2EC3-3310-45C4-8D7E-3243DD2E4D18Q44346286-A986BB4E-786B-4FEB-8B85-591C1F1B68E2Q46756382-4A0DB564-F6EF-4590-AC2A-CC226085CC65Q47318926-0DB3358D-DA89-4AFE-B635-567A6B345C5EQ48104554-7BF737B3-8F67-435B-BB21-3BD7F7115CCEQ52605912-DF322DA6-7FD1-4202-B415-C4F411F6EF87Q52640199-42DFEF48-10C4-405B-9A88-F3B181A997BAQ55006868-DA4DBAB0-ABF3-474C-9E7F-AA945E729CB1Q55013574-9DD6CB7E-98AA-4D14-8E93-684EBA030AB0
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lipid-based nanocarriers for oral peptide delivery.
@en
type
label
Lipid-based nanocarriers for oral peptide delivery.
@en
prefLabel
Lipid-based nanocarriers for oral peptide delivery.
@en
P2093
P50
P1476
Lipid-based nanocarriers for oral peptide delivery
@en
P2093
Brendan T Griffin
Inmaculada Conejos-Sánchez
María J Alonso
Zhigao Niu
P304
P356
10.1016/J.ADDR.2016.04.001
P407
P577
2016-04-11T00:00:00Z